Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due
to Number of Deaths
Herborium's AcnEase(R) Botanical Therapeutic(R) for Acne provides a safe
alternative for estrogen based treatments for hormonal acne
FORT LEE, N.J., Feb. 4, 2013
FORT LEE, N.J., Feb. 4, 2013 /PRNewswire/ --Herborium Group, Inc., (OTC Pink:
HBRM) www.herborium.com, a Botanical Therapeutics® Company discusses an impact
of a ban of Bayer's Diana-35 acne drug in Europe, and a follow up
investigation in Canada,on Herborium' s all botanical acne treatment
Diane-35 is a hormonal drug used to treat hormonal acne, especially those
resulting from too much of androgens (male hormones). It is also an oral
contraceptive (birth control pill). Diane-35 is not approved in the US but it
was available in Canada. Like many other drugs Diane-35 found its way to US
consumers though so called "gray marketing".
Diane-35 is presently investigated in Europe and Canada for number of deaths,
caused by blood clots, and for non-fatal cases of thrombosis and arterial
thrombosis associated with a use of a drug.
In September 2011, the U.S. Food and Drug Administration (FDA) has informed
the public that it has not yet reached a conclusion, but remains concerned,
about the potential increased risk of blood clots with the use of
drospirenone-containing birth control pills. Number of US approved
contraceptive pills including very popular Yasmin and Yuz were put on a
warning list. Despite of the warning, birth control pills are still rather
liberally prescribed to women with acne even if their sexual activity is not a
AcnEase® is all botanical ingredients based product that DOES NOT INCLUDE ANY
ESTROGEN. Furthermore, AcnEase® also DOES NOT include any phytoestrogens
(plant-derived estrogen-like substance). As phytoestrogens may be considered
safer that those made chemically they still act in a similar way and therefore
may not be suitable or safe for some consumers especially teens, women that
want to become pregnant, those who are pregnant or nursing, and of course men
suffering from hormonal acne.
"We are deeply saddened by a death and potential serious health implication
among Diane-35 patients. We are also determined to reiterate to our investors
and customers that a decision to base Herborium's differential advantage on
the use of proprietary, validated and safe botanical formulas has once again
been proven correct and most advantageous both strategically and ethically. We
will continue to provide safe and up to 96% effective AcnEase® to acne
sufferers in all markets, and to grow our market share in the multi-billion
dollar world-wide acne treatment sector,"commented Dr. Agnes P. Olszewski,
CEO and Chairwomen of Herborium Group.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on
developing, licensing, and marketing proprietary, botanical based medicinal
products to consumers and healthcare professionals. The Company uses clinical
validation to establish and maintain a differential advantage. The company
sells its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com
One of our most important responsibilities is to communicate with shareholders
in an open and direct manner. Comments are based on current management
expectations, and are considered "forward-looking statements," generally
preceded by words such as "plans," "expects," "believes," "anticipates," or
"intends." We cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or alter
forward-looking statements as the result of new information or future events.
The Company urges investors to review the risks and uncertainties contained
within its filings with the OTC Markets and/or Securities and Exchange
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
Press spacebar to pause and continue. Press esc to stop.